Stay updated on Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T14:25:06.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-04-23T13:50:08.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has undergone significant content removal, including the detailed description of a Phase 1/2 study evaluating Loncastuximab Tesirine and Ibrutinib for lymphoma treatment, which is critical information for potential participants and stakeholders. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    25%
    Check dated 2025-04-16T11:20:24.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T05:23:40.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T22:29:03.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-03-25T13:23:12.000Z thumbnail image

Stay in the know with updates to Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.